4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents.
Neeraj Shakya1, Satish Vedi1, Chao Liang1
1Department of Laboratory Medicine and Pathology, 7-28 Heritage Medical Research Centre, University of Alberta, Edmonton, AB T6G 2S2, Canada.
Researchers developed novel pyrimidine nucleosides to combat Hepatitis C virus (HCV) infection. Some compounds showed potent anti-HCV activity, outperforming ribavirin and exhibiting synergistic effects with it.
Area of Science:
- Medicinal Chemistry
- Virology
- Organic Synthesis
Background:
- Hepatitis C virus (HCV) infection poses a significant global health threat, potentially leading to severe liver diseases like cirrhosis and cancer.
- Current treatments for HCV can have limitations, necessitating the development of novel antiviral agents.
Purpose of the Study:
- To synthesize and evaluate a new class of pyrimidine nucleoside analogs for their anti-HCV activity.
- To identify compounds with potent inhibition of HCV replication and low cellular toxicity.
Main Methods:
- Synthesis of novel pyrimidine nucleosides featuring 4'-carboxymethyl or 4'-carboxamide functionalities.
- Antiviral screening using HCV-1a replicon cells to determine EC50 values.
- Cytotoxicity assays on Huh-7 cells to assess CC50 values.
- Synergistic interaction studies with ribavirin.
Main Results:
- Several synthesized pyrimidine nucleosides demonstrated potent anti-HCV activity, with EC50 values ranging from 33.1 to 59.5 μM.
- The most active compounds (e.g., 10-12, 14, 21) showed significantly higher efficacy than ribavirin (EC50 = 81.9 μM).
- These compounds exhibited no observable toxicity to Huh-7 cells (CC50 > 829 μM).
- Analog 12 displayed synergistic effects with ribavirin in inhibiting HCV RNA replication.
Conclusions:
- The novel pyrimidine nucleosides represent a promising new class of compounds for Hepatitis C treatment.
- The observed potent antiviral activity and favorable safety profile warrant further investigation of these analogs.
- Synergistic activity with existing drugs like ribavirin offers potential for enhanced therapeutic strategies against HCV.
More Related Videos
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
Published on: June 20, 2014
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Subviral Agents
Biosynthesis of Nucleic Acids
Viruses with RNA Genomes
Hepatitis
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
